Načítá se...
Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine
A paradigm-shift in the management of non-small cell lung cancer (NSCLC) has resulted in many new therapies becoming available for patients with advanced disease. Stratification of treatment by histologic and molecular subtype is recommended to obtain the greatest clinical benefit for patients while...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4170132/ https://ncbi.nlm.nih.gov/pubmed/25295228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00258 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|